Short Interest in Halberd Co. (OTCMKTS:HALB) Expands By 22.0%

Halberd Co. (OTCMKTS:HALB) was the target of a significant growth in short interest during the month of October. As of October 15th, there was short interest totalling 68,700 shares, a growth of 22.0% from the September 30th total of 56,300 shares. Based on an average daily trading volume, of 2,643,800 shares, the short-interest ratio is presently 0.0 days.

Halberd Price Performance

Halberd stock traded up $0.00 during midday trading on Wednesday, reaching $0.00. The company’s stock had a trading volume of 335,700 shares, compared to its average volume of 1,169,286. Halberd has a fifty-two week low of $0.00 and a fifty-two week high of $0.01. The stock’s 50 day simple moving average is $0.01 and its 200 day simple moving average is $0.01.

Halberd Company Profile

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.